Ayman Qasrawi, MD

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Sanofi
    Topic:
    Consultation Panel for cGVHD
    Date added:
    03/20/2026
    Date updated:
    03/20/2026
    Relationship end date:
    06/01/2025
Return to Hematologic Malignancy Tumor Board 4/6/2026